Cargando…
Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil
BACKGROUND: Early detection of leprosy and multidrug therapy are crucial to achieve zero transmission and zero grade II incapacities goals of World Health Organization. Leprosy is difficult to diagnose because clinical forms vary and there are no gold standard methods to guide clinicians. The serolo...
Autores principales: | Leturiondo, André Luiz, Noronha, Ariani Batista, do Nascimento, Monik Oney Oliveira, Ferreira, Cynthia de Oliveira, Rodrigues, Fabíola da Costa, Moraes, Milton Ozório, Talhari, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322275/ https://www.ncbi.nlm.nih.gov/pubmed/30616580 http://dx.doi.org/10.1186/s12879-018-3653-0 |
Ejemplares similares
-
Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO
por: Amorim, Francianne M., et al.
Publicado: (2016) -
Association between NDO-LID and PGL-1 for leprosy and class I and II human leukocyte antigen alleles in an indigenous community in Southwest Amazon
por: Teles, Stéfanie Ferreira, et al.
Publicado: (2020) -
Evaluation of antibody detection against the NDO-BSA, LID-1 and NDO-LID antigens as confirmatory tests to support the diagnosis of leprosy in Yunnan province, southwest China
por: Jian, Liu, et al.
Publicado: (2020) -
Utility of immunoglobulin isotypes against LID-1 and NDO-LID for,
particularly IgG1, confirming the diagnosis of multibacillary
leprosy
por: Marçal, Pedro Henrique Ferreira, et al.
Publicado: (2018) -
Leprosy: prevalence and factors associated with seropositivity for anti-NDO-LID antibodies in children under 15 years of age
por: Gomes, Luciane Cardoso, et al.
Publicado: (2019)